Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 7, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 42
- +6 vs. Q4 2025
- Portfolio value
- $423.5M
- −$15.2M (−3.5%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 827,901 | $50.2M | 11.9% | +81,946+11.0% | Added | History |
| MRKMerck & Co., Inc. | Stock | 260,340 | $31.3M | 7.4% | −103,311−28.4% | Reduced | History |
| PFEPfizer Inc | Stock | 1,091,385 | $30.6M | 7.2% | +231,846+27.0% | Added | History |
| MDTMedtronic plc | Stock | 280,682 | $24.3M | 5.7% | +11,038+4.1% | Added | History |
| INCYIncyte Corp | COM | 200,510 | $18.9M | 4.5% | −18,273−8.4% | Reduced | History |
| AMGNAmgen Inc | Stock | 47,155 | $16.6M | 3.9% | −13,801−22.6% | Reduced | History |
| BIIBBiogen Inc. | COM | 90,096 | $16.5M | 3.9% | +4,621+5.4% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 155,835 | $14.1M | 3.3% | +23,357+17.6% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 239,918 | $13.6M | 3.2% | +41,413+20.9% | Added | History |
| BDXBecton Dickinson & Co | Stock | 82,615 | $13.0M | 3.1% | −49,761−37.6% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 43,962 | $12.9M | 3.0% | +11,416+35.1% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 169,468 | $12.7M | 3.0% | −15,509−8.4% | Reduced | History |
| CAHCardinal Health Inc | Stock | 54,897 | $11.6M | 2.7% | −7,049−11.4% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 36,435 | $9.86M | 2.3% | +36,435 | New | History |
| CVSCVS Health Corp | Stock | 135,337 | $9.72M | 2.3% | −42,262−23.8% | Reduced | History |
| BRKRBruker Corp | COM | 254,010 | $9.17M | 2.2% | −687−0.3% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 126,418 | $9.00M | 2.1% | +12,028+10.5% | Added | History |
| ABTAbbott Laboratories | Stock | 87,532 | $8.99M | 2.1% | +87,532 | New | History |
| GILDGilead Sciences, Inc. | Stock | 53,247 | $7.42M | 1.8% | −123,167−69.8% | Reduced | History |
| LNTHLantheus Holdings, Inc. | Stock | 93,344 | $7.08M | 1.7% | −479−0.5% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 40,230 | $6.86M | 1.6% | +40,230 | New | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 286,007 | $6.68M | 1.6% | +33,945+13.5% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 23,750 | $6.62M | 1.6% | 00.0% | Unchanged | History |
| QGENQiagen N.V. | ORD SHARES | 162,371 | $6.50M | 1.5% | +162,371 | New | History |
| AVTRAvantor, Inc. | COM | 695,403 | $5.45M | 1.3% | 00.0% | Unchanged | History |
| CNCCentene Corp | Stock | 162,405 | $5.32M | 1.3% | −95,704−37.1% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 267,091 | $5.12M | 1.2% | 00.0% | Unchanged | History |
| PTCTPTC Therapeutics, Inc. | COM | 75,000 | $5.11M | 1.2% | +13,077+21.1% | Added | History |
| LHLabcorp Holdings Inc. | Stock | 19,019 | $5.07M | 1.2% | −8,000−29.6% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 21,305 | $4.87M | 1.2% | +5,000+30.7% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 60,402 | $4.84M | 1.1% | −36,000−37.3% | Reduced | History |
| DXCMDexcom Inc | COM | 56,122 | $3.52M | 0.8% | −20,000−26.3% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 94,195 | $3.42M | 0.8% | −20,805−18.1% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 411,810 | $3.35M | 0.8% | −44,031−9.7% | Reduced | History |
| HUMHumana Inc | Stock | 19,202 | $3.33M | 0.8% | +19,202 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 44,263 | $3.29M | 0.8% | +44,263 | New | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 900,000 | $3.16M | 0.7% | +900,000 | New | History |
| DNLIDenali Therapeutics Inc. | COM | 162,710 | $3.12M | 0.7% | +162,710 | New | History |
| ARDXArdelyx, Inc. | COM | 516,131 | $3.09M | 0.7% | +516,131 | New | History |
| COGTCogent Biosciences, Inc. | COM | 80,000 | $3.08M | 0.7% | +80,000 | New | History |
| OGNOrganon & Co. | Stock | 375,974 | $2.25M | 0.5% | +75,974+25.3% | Added | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 30,000 | $1.88M | 0.4% | +30,000 | New | History |
Sold out since Q4 2025 (5)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| TMOThermo Fisher Scientific Inc. | Stock | 21,688 | $12.6M | 2.9% | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 7,165 | $5.53M | 1.3% | History |
| HCAHCA Healthcare, Inc. | COM | 10,784 | $5.03M | 1.1% | History |
| CGONCG Oncology, Inc. | COM | 52,039 | $2.16M | 0.5% | History |
| CERTCertara, Inc. | COM | 230,565 | $2.03M | 0.5% | History |